Results of following up patients with chronic myeloid leukemia and a deep molecular response without tyrosine kinase inhibitor therapy

Results of following up patients with chronic myeloid leukemia and a deep molecular response without tyrosine kinase inhibitor therapy

Aim. To assess the results of following up patients with chronic myeloid leukemia (CML) and a deep molecular response (MR) without tyrosine kinase inhibitor (TKI) therapy. Subjects and methods. The reasons for TKI discontinuation in 70 patients with CML and a deep MR of more than 1 year’s duration w...

Full description

Bibliographic Details
Main Authors: A G Turkina, E Yu Chelysheva, V A Shuvaev, G A Gusarova, A V Bykova, O A Shukhov, A N Petrova, M V Vakhrusheva, S R Goryacheva, L Yu Kolosova, P S Krasikova, M S Fominykh, I S Martynkevich, A O Abdullaev, A B Sudarikov, V G Savchenko
Format: Article
Language:Russian
Published: "Consilium Medicum" Publishing house 2017-12-01
Series:Терапевтический архив
Subjects:
chronic myeloid leukemia
deep molecular response
remission without therapy
imatinib
nilotinib
dasatinib
Online Access:https://ter-arkhiv.ru/0040-3660/article/view/32357

Internet

https://ter-arkhiv.ru/0040-3660/article/view/32357

Similar Items